|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/498 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3576740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18702299.1 |
| Date of filing the European patent application | 2018-02-02 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-14 |
| (46) | Date of publication of the claims translation | 2023-08-10 |
| (86) | Number | PCT/EP2018/052694 |
| Date | 2018-02-02 |
| (87) | Number | WO 2018/141921 |
| Date | 2018-08-09 |
| (30) | Number | Date | Country code |
| 201762455211 P | 2017-02-06 | US | |
| 17209098 | 2017-12-20 | EP |
| (72) |
STUYCKENS, Kim , BE
PEREZ RUIXO, Juan, Jose , ES
DE PORRE, Peter, Marie, Z. , BE
AVADHANI, Anjali, Narayan , US
LORIOT, Yohann , FR
SIEFKER-RADTKE, Arlene, O. , BE
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Vėžio gydymas |
| CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2026-01-02 | 9 | 208.00 EUR |
| 2027-02-02 |